The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Peptide/Receptor Co-evolution Explains the Lipolytic Function of the Neuropeptide TLQP-21
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“C3aR is a G-protein coupled receptor showing prominent expression in tissue-resident macrophages[39,40] and is the target of two endogenous ligands, the C3-derived anaphylatoxin C3a, and the neural VGF-derived (non-acronymic) peptide TLQP-21[40–45].”
From Complement 3a Receptor mediates high fat diet induced hypothalamic accumulation of lipid associated microglia to regulate neuroinflammation and obesity (2026) · cites this paper as [45]
In the citing paper
“Recent studies implicate C3aR signaling in microglial activation in the context of neurodegeneration, and obesity-related conditions[43,45,48,65].”
From Complement 3a Receptor mediates high fat diet induced hypothalamic accumulation of lipid associated microglia to regulate neuroinflammation and obesity (2026) · cites this paper as [45]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Therapeutic peptides: Historical perspectives, current development trends, and future directions
Lau, J. L., & Dunn, M. K. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.06.052 · Cited by 1,879 · cited 1×
“Subtle species-specific differences in key amino acids in peptide pharmacophore and receptor binding pockets may compromise the ability to translate promising therapeutic efficacy from animal models to humans (Lahti et al., 2012; Lau and Dunn, 2018; Shimada et al., 2019).”
BackgroundAlternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis
Nguyen, K. D., Qiu, Y., Cui, X., Goh, Y. P. S., Mwangi, J., David, T., Mukundan, L., Brombacher, F., Locksley, R. M., & Chawla, A. (2011) · Nature · doi:10.1038/nature10653 · Cited by 1,038
Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects
James, W. P. T., Caterson, I. D., Coutinho, W., Finer, N., Van Gaal, L. F., Maggioni, A. P., Torp-Pedersen, C., Sharma, A. M., Shepherd, G. M., Rode, R. A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003114 · Cited by 943
How Ligands Illuminate GPCR Molecular Pharmacology
Wacker, D., Stevens, R. C., & Roth, B. L. (2017) · Cell · doi:10.1016/j.cell.2017.07.009 · Cited by 560 · cited 2×
“Importantly, GPCRs are associated with a large number of human diseases (Tschöp et al., 2016; Wacker et al., 2017), a finding that has stimulated, over the last several decades, increased interest in identifying their endogenous ligands and mechanism of activation as well as the development of pharmacological agonists…”
BackgroundBeyond the Sympathetic Tone: The New Brown Fat Activators
Villarroya, F., & Vidal-Puig, A. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.02.020 · Cited by 209
Anti-obesity therapy: from rainbow pills to polyagonists
Müller, T. D., Clemmensen, C., Finan, B., DiMarchi, R. D., & Tschöp, M. H. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014803 · Cited by 199
Clearance kinetics of the VGF-derived neuropeptide TLQP-21
Guo, Z., Sahu, B. S., He, R., Finan, B., Cero, C., Verardi, R., Razzoli, M., Veglia, G., Di Marchi, R. D., Miles, J. M., et al. (2018) · Neuropeptides · doi:10.1016/j.npep.2018.06.003 · Cited by 21
Self-citation
Research works printed but not linked: 74
- Ahmed, 2014, Predicting the molecular interactions of CRIP1a-cannabinoid 1 receptor with integrated molecular modeling approaches, Bioorg. Med. Chem. Lett., 24, 1158, 10.1016/j.bmcl.2013.12.119 · DOI
- Arner, 1999, Catecholamine-induced lipolysis in obesity, Int. J. Obes. Relat. Metab. Disord., 23, 10, 10.1038/sj.ijo.0800789 · DOI · Paper page
- Bandyopadhyay, 2012, Catestatin (chromogranin A(352-372)) and novel effects on mobilization of fat from adipose tissue through regulation of adrenergic and leptin signaling, J. Biol. Chem., 287, 23141, 10.1074/jbc.M111.335877 · DOI
- Bartolomucci, 2006, TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesity, Proc. Natl. Acad. Sci. USA, 103, 14584, 10.1073/pnas.0606102103 · DOI · Paper page
- Bartolomucci, 2011, The extended granin family: structure, function, and biomedical implications, Endocr. Rev., 32, 755, 10.1210/er.2010-0027 · DOI · Paper page
- Beard, 2013, Applying physics-based scoring to calculate free energies of binding for single amino acid mutations in protein-protein complexes, PLoS ONE, 8, e82849, 10.1371/journal.pone.0082849 · DOI · Paper page
- Cero, 2014, The TLQP-21 peptide activates the G-protein-coupled receptor C3aR1 via a folding-upon-binding mechanism, Structure, 22, 1744, 10.1016/j.str.2014.10.001 · doi:10.1016/j.str.2014.10.001
- Cero, 2016, The neuropeptide TLQP-21 opposes obesity via C3aR1-mediated enhancement of adrenergic-induced lipolysis, Mol. Metab., 6, 148, 10.1016/j.molmet.2016.10.005 · DOI · Paper page
- Chakraborty, 2015, Probing the Conformational Dynamics of the Bioactive Peptide TLQP-21 in Solution: A Molecular Dynamics Study, Chem. Biol. Drug Des., 86, 938, 10.1111/cbdd.12541 · doi:10.1111/cbdd.12541
- Chao, 1999, Role of the second extracellular loop of human C3a receptor in agonist binding and receptor function, J. Biol. Chem., 274, 9721, 10.1074/jbc.274.14.9721 · DOI
- Clapham, 2011, Targeting thermogenesis and related pathways in anti-obesity drug discovery, Pharmacol. Ther., 131, 295, 10.1016/j.pharmthera.2011.04.004 · DOI
- Clemmensen, 2019, Emerging hormonal-based combination pharmacotherapies for the treatment of metabolic diseases, Nat. Rev. Endocrinol., 15, 90, 10.1038/s41574-018-0118-x · DOI
- Coulthard, 2015, Is the complement activation product C3a a proinflammatory molecule? Re-evaluating the evidence and the myth, J. Immunol., 194, 3542, 10.4049/jimmunol.1403068 · DOI · Paper page
- Doolen, 2017, Complement 3a receptor in dorsal horn microglia mediates pronociceptive neuropeptide signaling, Glia, 65, 1976, 10.1002/glia.23208 · DOI · Paper page
- Ember, 1991, Designing synthetic superagonists of C3a anaphylatoxin, Biochemistry, 30, 3603, 10.1021/bi00229a003 · DOI
- Falls, 2018, Insights into the Allosteric Mechanism of Setmelanotide (RM-493) as a Potent and First-in-Class Melanocortin-4 Receptor (MC4R) Agonist To Treat Rare Genetic Disorders of Obesity through an in Silico Approach, ACS Chem. Neurosci., 10, 1055, 10.1021/acschemneuro.8b00346 · DOI
- Fargali, 2014, The granin VGF promotes genesis of secretory vesicles, and regulates circulating catecholamine levels and blood pressure, FASEB J., 28, 2120, 10.1096/fj.13-239509 · doi:10.1096/fj.13-239509
- Gerardy-Schahn, 1988, Design and biological activity of a new generation of synthetic C3a analogues by combination of peptidic and non-peptidic elements, Biochem. J., 255, 209
- Granneman, 2008, Location, location: protein trafficking and lipolysis in adipocytes, Trends Endocrinol. Metab., 19, 3, 10.1016/j.tem.2007.10.006 · DOI
- Hannedouche, 2013, Identification of the C3a receptor (C3AR1) as the target of the VGF-derived peptide TLQP-21 in rodent cells, J. Biol. Chem., 288, 27434, 10.1074/jbc.M113.497214 · DOI
- Hauser, 2017, Trends in GPCR drug discovery: new agents, targets and indications, Nat. Rev. Drug Discov., 16, 829, 10.1038/nrd.2017.178 · DOI · Paper page
- Hollmann, 1998, Cloning, expression, sequence determination, and chromosome localization of the mouse complement C3a anaphylatoxin receptor gene, Mol. Immunol., 35, 137, 10.1016/S0161-5890(98)00021-2 · DOI
- Hugli, 1978, Anaphylatoxins: C3a and C5a, Adv. Immunol., 26, 1, 10.1016/S0065-2776(08)60228-X · DOI · Paper page
- Jethwa, 2007, VGF-derived peptide, TLQP-21, regulates food intake and body weight in Siberian hamsters, Endocrinology, 148, 4044, 10.1210/en.2007-0038 · doi:10.1210/en.2007-0038
- Jorgensen, 1983, Comparison of simple potential functions for simulating liquid water, J. Chem. Phys., 79, 926, 10.1063/1.445869 · DOI · Paper page
- Jorgensen, 1996, Development and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids, J. Am. Chem. Soc., 118, 11225, 10.1021/ja9621760 · DOI · Paper page
- Klos, 2013, International Union of Basic and Clinical Pharmacology. [corrected]. LXXXVII. Complement peptide C5a, C4a, and C3a receptors, Pharmacol. Rev., 65, 500, 10.1124/pr.111.005223 · DOI · Paper page
- Kroeze, 2015, PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome, Nat. Struct. Mol. Biol., 22, 362, 10.1038/nsmb.3014 · DOI · Paper page
- Krout, 2017, The TRPC1 Ca2+-permeable channel inhibits exercise-induced protection against high-fat diet-induced obesity and type II diabetes, J. Biol. Chem., 292, 20799, 10.1074/jbc.M117.809954 · DOI
- Lafontan, 2009, Lipolysis and lipid mobilization in human adipose tissue, Prog. Lipid Res., 48, 275, 10.1016/j.plipres.2009.05.001 · DOI · Paper page
- Lahti, 2012, Bioinformatics and variability in drug response: a protein structural perspective, J. R. Soc. Interface, 9, 1409, 10.1098/rsif.2011.0843 · DOI
- Liao, 2014, The TRPC Family of TRP Channels: Roles Inferred (Mostly) from Knockout Mice and Relationship to ORAI Proteins, Handb. Exp. Pharmacol., 223, 1055, 10.1007/978-3-319-05161-1_14 · doi:10.1007/978-3-319-05161-1_14
- Liu, 2012, Enhanced store-operated Ca2+ entry and TRPC channel expression in pulmonary arteries of monocrotaline-induced pulmonary hypertensive rats, Am. J. Physiol. Cell Physiol., 302, C77, 10.1152/ajpcell.00247.2011 · DOI
- Liu, 2018, Orthosteric and allosteric action of the C5a receptor antagonists, Nat. Struct. Mol. Biol., 25, 472, 10.1038/s41594-018-0067-z · DOI
- Lo, 2014, Adipsin is an adipokine that improves β cell function in diabetes, Cell, 158, 41, 10.1016/j.cell.2014.06.005 · DOI · Paper page
- Lönnqvist, 1992, Lipolytic catecholamine resistance due to decreased beta 2-adrenoceptor expression in fat cells, J. Clin. Invest., 90, 2175, 10.1172/JCI116103 · DOI
- Lotta, 2019, Human Gain-of-Function MC4R Variants Show Signaling Bias and Protect against Obesity, Cell, 177, 597, 10.1016/j.cell.2019.03.044 · DOI · Paper page
- Mahata, 1997, Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist, J. Clin. Invest., 100, 1623, 10.1172/JCI119686 · DOI · Paper page
- Mamane, 2009, The C3a anaphylatoxin receptor is a key mediator of insulin resistance and functions by modulating adipose tissue macrophage infiltration and activation, Diabetes, 58, 2006, 10.2337/db09-0323 · DOI · Paper page
- Mason, 2011, Bimodal distribution of RNA expression levels in human skeletal muscle tissue, BMC Genomics, 12, 98, 10.1186/1471-2164-12-98 · DOI
- McCorvy, 2018, Structural determinants of 5-HT2B receptor activation and biased agonism, Nat. Struct. Mol. Biol., 25, 787, 10.1038/s41594-018-0116-7 · DOI · Paper page
- Molteni, 2017, Pharmacological and Biochemical Characterization of TLQP-21 Activation of a Binding Site on CHO Cells, Front. Pharmacol., 8, 167, 10.3389/fphar.2017.00167 · DOI
- Mowers, 2013, Inflammation produces catecholamine resistance in obesity via activation of PDE3B by the protein kinases IKKε and TBK1, eLife, 2, e01119, 10.7554/eLife.01119 · DOI
- Pandey, 2019, Partial ligand-receptor engagement yields functional bias at the human complement receptor, C5aR1, J. Biol. Chem., 294, 9416, 10.1074/jbc.RA119.007485 · DOI
- Papadopoulos, 2007, COBALT: constraint-based alignment tool for multiple protein sequences, Bioinformatics, 23, 1073, 10.1093/bioinformatics/btm076 · DOI · Paper page
- Pellegrinelli, 2018, Adipocyte-secreted BMP8b mediates adrenergic-induced remodeling of the neuro-vascular network in adipose tissue, Nat. Commun., 9, 4974, 10.1038/s41467-018-07453-x · DOI
- Petrocchi Passeri, 2013, Neuropeptide TLQP-21, a VGF internal fragment, modulates hormonal gene expression and secretion in GH3 cell line, Neuroendocrinology, 97, 212, 10.1159/000339855 · doi:10.1159/000339855
- Pinilla, 2011, Characterization of the reproductive effects of the anorexigenic VGF-derived peptide TLQP-21: in vivo and in vitro studies in male rats, Am. J. Physiol. Endocrinol. Metab., 300, E837, 10.1152/ajpendo.00598.2010 · DOI
- Pirzgalska, 2017, Sympathetic neuron-associated macrophages contribute to obesity by importing and metabolizing norepinephrine, Nat. Med., 23, 1309, 10.1038/nm.4422 · DOI · Paper page
- Possenti, 2012, Characterization of a novel peripheral pro-lipolytic mechanism in mice: role of VGF-derived peptide TLQP-21, Biochem. J., 441, 511, 10.1042/BJ20111165 · doi:10.1042/bj20111165
- Quell, 2017, Monitoring C3aR Expression Using a Floxed tdTomato-C3aR Reporter Knock-in Mouse, J. Immunol., 199, 688, 10.4049/jimmunol.1700318 · DOI · Paper page
- Rapold, 2013, Fas activates lipolysis in a Ca2+-CaMKII-dependent manner in 3T3-L1 adipocytes, J. Lipid Res., 54, 63, 10.1194/jlr.M028035 · DOI
- Regal, 2000, Minor role of the C3a receptor in systemic anaphylaxis in the guinea pig, Immunopharmacology, 46, 15, 10.1016/S0162-3109(99)00152-6 · doi:10.1016/s0162-3109(99)00152-6
- Regal, 1993, Role of the complement system in antigen-induced bronchoconstriction and changes in blood pressure in the guinea pig, J. Pharmacol. Exp. Ther., 267, 979, 10.1016/S0022-3565(25)39575-3 · doi:10.1016/s0022-3565(25)39575-3
- Reid, 2013, Downsizing a human inflammatory protein to a small molecule with equal potency and functionality, Nat. Commun., 4, 2802, 10.1038/ncomms3802 · doi:10.1038/ncomms3802
- Reilly, 2017, Adapting to obesity with adipose tissue inflammation, Nat. Rev. Endocrinol., 13, 633, 10.1038/nrendo.2017.90 · DOI · Paper page
- Rivolta, 2017, JMV5656, A Novel Derivative of TLQP-21, Triggers the Activation of a Calcium-Dependent Potassium Outward Current in Microglial Cells, Front. Cell. Neurosci., 11, 41, 10.3389/fncel.2017.00041 · DOI
- Robertson, 2018, Structure of the complement C5a receptor bound to the extra-helical antagonist NDT9513727, Nature, 553, 111, 10.1038/nature25025 · DOI
- Rodgers, 2012, Anti-obesity drugs: past, present and future, Dis. Model. Mech., 5, 621, 10.1242/dmm.009621 · DOI · Paper page
- Roglic, 1996, cDNA cloning of a novel G protein-coupled receptor with a large extracellular loop structure, Biochim. Biophys. Acta, 1305, 39, 10.1016/0167-4781(95)00209-X · doi:10.1016/0167-4781(95)00209-x
- Sabourin, 2016, Transient Receptor Potential Canonical (TRPC)/Orai1-dependent Store-operated Ca2+ Channels: NEW TARGETS OF ALDOSTERONE IN CARDIOMYOCYTES, J. Biol. Chem., 291, 13394, 10.1074/jbc.M115.693911 · DOI
- Sadaghiani, 2014, Identification of Orai1 channel inhibitors by using minimal functional domains to screen small molecule microarrays, Chem. Biol., 21, 1278, 10.1016/j.chembiol.2014.08.016 · DOI
- Sexton, 2016, The contribution of TRPC1, TRPC3, TRPC5 and TRPC6 to touch and hearing, Neurosci. Lett., 610, 36, 10.1016/j.neulet.2015.10.052 · DOI
- Shah, 2014, Do you know the sex of your cells?, Am. J. Physiol. Cell Physiol., 306, C3, 10.1152/ajpcell.00281.2013 · DOI · Paper page
- Shimada, 2019, GPCR drug discovery: integrating solution NMR data with crystal and cryo-EM structures, Nat. Rev. Drug Discov., 18, 59, 10.1038/nrd.2018.180 · DOI · Paper page
- Singh, 2010, The transient receptor potential channel antagonist SKF96365 is a potent blocker of low-voltage-activated T-type calcium channels, Br. J. Pharmacol., 160, 1464, 10.1111/j.1476-5381.2010.00786.x · DOI · Paper page
- Stephens, 2012, A VGF-derived peptide attenuates development of type 2 diabetes via enhancement of islet β-cell survival and function, Cell Metab., 16, 33, 10.1016/j.cmet.2012.05.011 · doi:10.1016/j.cmet.2012.05.011
- Still, 1990, Semianalytical treatment of solvation for molecular mechanics and dynamics, J. Am. Chem. Soc., 112, 6127, 10.1021/ja00172a038 · DOI · Paper page
- Sukumar, 2012, Constitutively active TRPC channels of adipocytes confer a mechanism for sensing dietary fatty acids and regulating adiponectin, Circ. Res., 111, 191, 10.1161/CIRCRESAHA.112.270751 · DOI
- Sun, 1999, Identification of ligand effector binding sites in transmembrane regions of the human G protein-coupled C3a receptor, Protein Sci., 8, 2304, 10.1110/ps.8.11.2304 · DOI
- Tschöp, 2016, Unimolecular Polypharmacy for Treatment of Diabetes and Obesity, Cell Metab., 24, 51, 10.1016/j.cmet.2016.06.021 · DOI · Paper page
- Vazquez, 2004, The mammalian TRPC cation channels, Biochim. Biophys. Acta, 1742, 21, 10.1016/j.bbamcr.2004.08.015 · DOI · Paper page
- Whittle, 2012, BMP8B increases brown adipose tissue thermogenesis through both central and peripheral actions, Cell, 149, 871, 10.1016/j.cell.2012.02.066 · DOI · Paper page
- Zhang, 2005, Homology modeling and molecular dynamics simulations of the mu opioid receptor in a membrane-aqueous system, ChemBioChem, 6, 853, 10.1002/cbic.200400207 · doi:10.1002/cbic.200400207
Cited by
El Gaamouch, F., Audrain, M., Lin, W.-J., Beckmann, N., Jiang, C., Hariharan, S., Heeger, P. S., Schadt, E. E., Gandy, S., Ehrlich, M. E., et al. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-0357-x · Cited by 92
Pallais, J. P., Razzoli, M., Rodriguez, P., McGonigle, S., Daugherty, A., Hillman, H., Verteramo, L., Schrank, P. R., Parthiban, P., Chang, X., et al. (2026) · doi:10.64898/2026.04.18.719397 · Cited by 1
Self-citation
Metadata
- Authors
- Sahu, B. S., Rodriguez, P., Nguyen, M. E., Han, R., Cero, C., Razzoli, M., Piaggi, P., Laskowski, L. J., Pavlicev, M., Muglia, L., Mahata, S. K., O’Grady, S., McCorvy, J. D., Baier, L. J., Sham, Y. Y., & Bartolomucci, A.
- Venue
- Cell Reports
- Publisher
- Elsevier BV
- Published
- 2019-09
- Volume
- 28
- Issue
- 10
- Pages
- 2567-2580.e6
- ISSN
- 2211-1247
- Cited by
- 26
- References
- 7
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Funders
- National Institutes of Health (AI128729)
- National Institute of Diabetes and Digestive and Kidney Diseases (JCSTF-180217, DK117504, / NIDDK DK102496)
- U.S. Department of Veterans Affairs (BT-/RLF/Re-entry/38/2016, I01BX000323)
- Department of Biotechnology, Ministry of Science and Technology, India
- Company of Biologists (JCSTF-180217)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Peptide/Receptor Co-evolution Explains the Lipolytic Function of the Neuropeptide TLQP-21. https://app.cochat.ai/papers/10.1016/j.celrep.2019.07.101
- The paper
- Sahu, B. S., Rodriguez, P., Nguyen, M. E., Han, R., Cero, C., Razzoli, M., Piaggi, P., Laskowski, L. J., Pavlicev, M., Muglia, L., Mahata, S. K., O’Grady, S., McCorvy, J. D., Baier, L. J., Sham, Y. Y., & Bartolomucci, A. (2019). Peptide/Receptor Co-evolution Explains the Lipolytic Function of the Neuropeptide TLQP-21. Cell Reports. https://doi.org/10.1016/j.celrep.2019.07.101
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.